Drug
Hylan clinical trials
Also written Synvisc®.
How studies write it
Studies that test it under each name
Name
Brand
Studies by the year they started
8 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 5
Genzyme, a Sanofi Company (1) · Hospital for Special Surgery, New York (1) · Sanofi (1) · Boehringer Ingelheim (1) · Thammasat University (1) · Universidade Federal Fluminense (1) · Meir Medical Center (1) · Grant Jones (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses hylan is read from its arms, and is right about nine times in ten.
Testing it · 8
- Study of Viscosupplementation for the Treatment of Knee Pain After MenisectomyWithdrawnNot applicableGrant JonesNCT00971074Written as Hylan G-F 20
- Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat TreatmentCompletedPhase 4Genzyme, a Sanofi CompanyNCT02389452Written as Synvisc-One
- A Study of Hyaluronan for the Treatment of Osteoarthritis in the ThumbCompletedPhase 3Hospital for Special Surgery, New YorkNCT00398866Written as Synvisc (Hylan G-F20; hyaluronan injection)
- Outcomes of Injections in Patients Waiting for Total Knee ReplacementStatus unknownPhase 4Universidade Federal FluminenseNCT03090698Written as Hylan G-F 20
- A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s)CompletedPhase 4SanofiNCT01586338Written as Hylan G-F 20
- Treatment of Insertional Achilles Tendinopathy by Hyaluronic Acid InjectionStatus unknownEarly Phase 1Meir Medical CenterNCT02368561Written as Injection of Hyaluronic Acid -" SYNVISC" (hylan G-F 20)
- Effectiveness and Safety of Synvisc® Versus Usual Treatments in Patients With Knee OsteoarthritisCompletedPhase 4Boehringer IngelheimNCT02197026Written as Hylan G-F 20
- Intra-articular Corticosteroid Injection Compared With Single-Shot Hyaluronic Acid for Treatment of Osteoarthritis KneeCompletedPhase 4Thammasat UniversityNCT01874574Written as Hylan G-F 20
As the comparator · 4 — what is tested is compared with hylan
- Comparison of Single Intra-articular Injection of Hyruan-One With Hylan G-F 20 in Knee OsteoarthritisCompletedPhase 4Thammasat UniversityNCT03484091Written as Hylan G-F 20
- A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of OsteoarthritisCompletedPhase 2Nature Cell Co. Ltd.NCT02674399Written as Synvisc-One
- Knee Injection RCTTerminatedPhase 4UConn HealthNCT03694821Written as Hylan G-F 20
- Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in CoxarthrosisCompletedPhase 3Fundación Pública Andaluza Progreso y SaludNCT02694146Written as Hylan G-F 20
Codes
What other systems call hylan · ClinicalTrials.gg INT003285
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C049816 | hylan | One source ClinicalTrials.gov |
| RxNorm | 284637 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.